Skip to main content
Fig. 5 | BMC Genomics

Fig. 5

From: Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance

Fig. 5

NAT1 expression and response to drug treatment. a NAT1 mRNA in patients receiving no drug treatment (n = 385) plotted against overall survival of 1 to 5 years or greater than 5 years. b NAT1 mRNA in patients receiving hormone therapy (n = 1121). c NAT1 mRNA in patients receiving chemotherapy (n = 375). d Decision plot of sensitivity (left axis) and specificity (right axis) for NAT1 mRNA to predict drug resistance (< 5 years survival) or sensitivity (> 5 years survival) against NAT1 mRNA cut-off

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us